These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33537999)

  • 1. Efficacy and safety of restarting antiplatelet therapy for patients with spontaneous intracranial haemorrhage: A systematic review and meta-analysis.
    Cheng B; Li J; Peng L; Wang Y; Sun L; He S; Wei J; Zhang S
    J Clin Pharm Ther; 2021 Aug; 46(4):957-965. PubMed ID: 33537999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic differences in restarting antiplatelet therapy in patients with primary intracranial hemorrhage: a systematic review and meta-analysis.
    Wang X; Chen T; Zhou J; Qin Y
    BMC Neurol; 2024 Aug; 24(1):280. PubMed ID: 39127615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: A meta-analysis of cohort studies.
    Ding X; Liu X; Tan C; Yin M; Wang T; Liu Y; Mo L; Wei X; Tan X; Deng F; Chen L
    J Neurol Sci; 2018 Jan; 384():133-138. PubMed ID: 29153510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage.
    Jung NY; Cho J
    Clin Neurol Neurosurg; 2022 Sep; 220():107361. PubMed ID: 35835024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and benefit of reinitiating antiplatelet therapy after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.
    Zhang JW; Zhao JX; Yin GF
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2686-2695. PubMed ID: 38639508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
    Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
    Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    RESTART Collaboration
    Lancet; 2019 Jun; 393(10191):2613-2623. PubMed ID: 31128924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage.
    Baschin M; Selleng S; Zeden JP; Westphal A; Kohlmann T; Schroeder HW; Greinacher A; Thiele T
    Vox Sang; 2017 Aug; 112(6):535-541. PubMed ID: 28809046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs.
    Pomero F; Melchio R; Sironi A; Giraudo AV; Dentali F; Fenoglio LM; Squizzato A
    Thromb Res; 2013; 132(6):765-9. PubMed ID: 24157084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
    Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
    CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior Antiplatelet Therapy, Excluding Phosphodiesterase Inhibitor Is Associated with Poor Outcome in Patients with Spontaneous Intracerebral Haemorrhage.
    Liu ZH; Liu CH; Tu PH; Yip PK; Chen CC; Wang YC; Chen NY; Lin YS
    Transl Stroke Res; 2020 Apr; 11(2):185-194. PubMed ID: 31446619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy].
    Varvat J; Epinat M; Nuti C; Antoine JC; Mismetti P; Garnier P
    Therapie; 2013; 68(3):143-7. PubMed ID: 23886458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
    Al-Shahi Salman R; Dennis MS; Murray GD; Innes K; Drever J; Dinsmore L; Williams C; White PM; Whiteley WN; Sandercock PAG; Sudlow CLM; Newby DE; Sprigg N; Werring DJ;
    Trials; 2018 Mar; 19(1):162. PubMed ID: 29506580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
    Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Zomorodi A; Friedman A; Awad I; Jabbour PM; Hasan DM
    J Am Heart Assoc; 2024 Mar; 13(6):e032910. PubMed ID: 38471833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative antiplatelet therapy may be a risk factor for postoperative ischemic complications in intracranial hemorrhage patients.
    Yang J; Wang K; Han C; Liu Q; Zhang S; Wu J; Jiang P; Yang S; Guo R; Mo S; Yang Y; Zhang J; Liu Y; Cao Y; Wang S
    Int J Neurosci; 2024 Aug; 134(8):899-905. PubMed ID: 36503400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016.
    Newman TV; Chen N; He M; Saba S; Hernandez I
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantity of Cerebral Microbleeds, Antiplatelet Therapy, and Intracerebral Hemorrhage Outcomes: A Systematic Review and Meta-analysis.
    Wang DN; Hou XW; Yang BW; Lin Y; Shi JP; Wang N
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2728-37. PubMed ID: 26342996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.